Research output per year
Research output per year
Search results
-
2023
Tissue-Based PD-L1 Expression Is the Strongest Predictor of Overall Survival Benefit from ICI in Advanced Gastroesophageal Cancer - Reply
Yoon, H. H., Shi, Q. & Ajani, J. A., Feb 16 2023, In: JAMA Oncology. 9, 2, p. 280-281 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
2021
Ramucirumab plus paclitaxel for gastric cancer in China
Yoon, H. H., Dec 2021, In: The Lancet Gastroenterology and Hepatology. 6, 12, p. 975-976 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Trifluridine/tipiracil plus ramucirumab in gastric cancer
Zhu, M., Sonbol, M. B. & Yoon, H. H., Mar 2021, In: The Lancet Gastroenterology and Hepatology. 6, 3, p. 154-155 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
2019
Corrigendum: Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: A randomized, double-blind, multicenter Phase II trial (Annals of Oncology (2016) 27 (2196-2203) DOI: 10.1093/annonc/mdw423)
Yoon, H. H., Bendell, J. C., Braiteh, F. S., Firdaus, I., Philip, P. A., Cohn, A. L., Lewis, N., Anderson, D. M., Arrowsmith, E., Schwartz, J. D., Gao, L., Hsu, Y., Xu, Y., Ferry, D., Alberts, S. R. & Wainberg, Z. A., Dec 1 2019, In: Annals of Oncology. 30, 12, p. 2016 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Scopus citations